Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Colorectal cancer

Strategies to minimize interval CRC in screening programmes

Nature Reviews Gastroenterology & Hepatology volume 13, pages 10–12 (2016)Cite this article

Subjects

The interval colorectal cancer rate is a robust indicator of the quality and effectiveness of a screening programme, enabling the identification of unmet requirements and development of specific strategies to resolve them. A recent study demonstrated the use of interval cancer as an indicator to target quality improvement of colonoscopy in a screening programme.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Chiu, S. Y. et al. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program. Gut http://dx.doi.org/gutjnl-2015-310256 (2015).

  2. Stoop, E. M. et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol. 13, 55–64 (2012).

    Article  Google Scholar 

  3. van Rossum, L. G. et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135, 82–90 (2008).

    Article  Google Scholar 

  4. de Wijkerslooth, T. R. et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am. J. Gastroenterol. 107, 1570–1578 (2012).

    Article  CAS  Google Scholar 

  5. Sanduleanu, S. et al. Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut 64, 1257–1267 (2015).

    Article  CAS  Google Scholar 

  6. le Clercq, C. M. et al. Metachronous colorectal cancers result from missed lesions and non-compliance with surveillance. Gastrointest. Endosc. 82, 325–333 (2015).

    Article  Google Scholar 

  7. Kaminski, M. F. et al. Quality indicators for colonoscopy and the risk of interval cancer. N. Engl. J. Med. 362, 1795–1803 (2010).

    Article  CAS  Google Scholar 

  8. Corley, D. A. et al. Adenoma detection rate and risk of colorectal cancer and death. N. Engl. J. Med. 370, 1298–1306 (2014).

    Article  CAS  Google Scholar 

  9. Hazewinkel, Y. & Dekker, E. Colonoscopy: basic principles and novel techniques. Nat. Rev. Gastroenterol. Hepatol. 8, 554–564 (2011).

    Article  Google Scholar 

  10. Lee, T. J. et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut 61, 1050–1057 (2012).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Evelien Dekker is at the Department of Gastroenterology & Hepatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands.,

    Evelien Dekker

  2. Silvia Sanduleanu is at the Department of Gastroenterology & Hepatology, Maastricht University Medical Center and GROW School for Oncology and Developmental Biology, P. Debyelaan 25, 6229 HX Maastricht, Netherlands.,

    Silvia Sanduleanu

Authors
  1. Evelien Dekker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvia Sanduleanu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Evelien Dekker.

Ethics declarations

Competing interests

E.D. declares a research grant and endoscopic equipment on loan from Olympus Europe as well as equipment on loan from Fuji Japan. S.S. has a research grant and endoscopic equipment on loan from Pentax Europe.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dekker, E., Sanduleanu, S. Strategies to minimize interval CRC in screening programmes. Nat Rev Gastroenterol Hepatol 13, 10–12 (2016). https://doi.org/10.1038/nrgastro.2015.216

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2015.216

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer